New minimally invasive biomarker test enables earlier diagnosis and improved clinical decision-making, aligned with global guidelines
As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
The summit brought together over 150 doctors, researchers, and practitioners worldwide
Multidisciplinary team expansion brings integrated medical, surgical, and radiation oncology services under one roof
Multi-stakeholder initiative highlights inclusive sports pathways, honours neurodivergent athletes, and calls for systemic reforms
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
New facility offers genetic testing, counselling and personalised treatment plans to enable early diagnosis and precision-led care
Shares issued under ESOP 2008 and MESOP 2018 plans following exercise of vested stock options, in compliance with SEBI disclosure norms
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
Subscribe To Our Newsletter & Stay Updated
